UK MHRA completes inspection at Lupin’s Goa facility

16 Jul 2018 Evaluate

United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has successfully completed inspection of Lupin’s Goa facility in March, 2018. There were no critical or major observations in the inspection.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2189.75 8.30 (0.38%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×